U.S. Residential REITs Stock News

NasdaqGM:CAMT
NasdaqGM:CAMTSemiconductor

Why Camtek (CAMT) Is Up 13.0% After Issuing Bullish 2026 Outlook On AI-Focused Growth

In February 2026, Camtek Ltd. reported its fourth‑quarter 2025 results, with sales rising to US$128.12 million and net income to US$35.9 million, alongside higher quarterly earnings per share than a year earlier. Despite full‑year 2025 net income dropping to US$50.72 million even as sales grew to US$496.07 million, management issued upbeat 2026 guidance, highlighting expected double‑digit revenue growth supported by a solid backlog and customer pipeline. We’ll now examine how Camtek’s...
NasdaqGS:TPG
NasdaqGS:TPGCapital Markets

A Look At TPG (TPG) Valuation After Concerns Over Market Financial Solutions Exposure

TPG (TPG) stock has come under pressure after investors focused on its £44 million exposure to failed UK mortgage lender Market Financial Solutions, which faces a reported £930 million collateral shortfall. See our latest analysis for TPG. The £44 million exposure to Market Financial Solutions comes on top of other recent headlines for TPG, including its role in a US$450 million Xerox joint venture financing and interest in the MarineMax sale process. Despite those developments, the share...
NYSE:ALTG
NYSE:ALTGTrade Distributors

Alta Equipment Group Q4 Losses Deepen Concerns Around Bullish Margin Narratives

Alta Equipment Group (ALTG) has reported fourth quarter FY 2025 revenue of US$509.1 million with a basic EPS loss of US$0.39, setting the tone for a year where the business stayed focused on scale while earnings remained in the red. The company has seen quarterly revenue move from US$448.8 million in Q3 2024 to US$498.1 million in Q4 2024, then to US$423.0 million in Q1 2025 and up to US$509.1 million in Q4 2025, while basic EPS over that stretch ranged from a loss of US$0.34 to a loss of...
NasdaqCM:WULF
NasdaqCM:WULFSoftware

TeraWulf (WULF) TTM Loss Of US$661 Million Tests Bullish Margin Improvement Narrative

TeraWulf (WULF) closed FY 2025 with Q4 revenue of US$35.8 million and a basic EPS loss of US$0.30, alongside a trailing twelve month revenue base of US$168.5 million and a full year EPS loss of US$1.66. Over the last six reported quarters, revenue has ranged from US$27.1 million in Q3 2024 to US$50.6 million in Q3 2025, while quarterly basic EPS losses have moved between US$0.05 and US$1.13. This gives investors a clear picture of a business still working through heavy losses. With trailing...
NYSE:HPP
NYSE:HPPOffice REITs

Hudson Pacific Properties (HPP) FFO Hovering Near Breakeven Challenges Bearish Narratives

Hudson Pacific Properties (HPP) closed out FY 2025 with Q4 revenue of US$256.0 million and basic EPS of US$4.31 loss, while trailing twelve month revenue came in at US$831.1 million alongside a TTM basic EPS of US$12.81 loss. This gives investors a clear snapshot of pressure on per share results. Over recent periods, the company has seen quarterly revenue shift from US$208.8 million in Q4 2024 to US$256.0 million in Q4 2025, with basic EPS moving from a loss of US$8.28 per share to a loss of...
NYSE:DK
NYSE:DKOil and Gas

Delek US Holdings (DK) Posts Q4 Profit While TTM Loss Keeps Bearish Narrative Intact

Delek US Holdings (DK) closed out FY 2025 with Q4 revenue of US$2,429.4 million and basic EPS of US$1.32, alongside net income from continuing operations of US$79.5 million. Over the past few quarters, revenue has moved between US$2,641.9 million and US$2,887 million while basic EPS has swung from a loss of US$2.78 in Q1 2025 to a profit of US$2.96 in Q3 2025 and then US$1.32 in Q4, highlighting the sensitivity of margins to refining conditions and product mix. See our full analysis for Delek...
NasdaqGS:CCCC
NasdaqGS:CCCCBiotechs

C4 Therapeutics (CCCC) Quarterly Loss Narrows To US$20.5m Challenging Persistent Bearish Narratives

C4 Therapeutics (CCCC) just posted its FY 2025 Q4 numbers, with revenue of US$11.0 million and a quarterly loss translating to basic EPS of US$0.18, set against a trailing twelve month loss of US$105.0 million and EPS of US$1.27 on revenue of US$35.9 million. Over recent quarters, the company has seen revenue move between US$5.2 million and US$15.4 million, while quarterly EPS has ranged from US$0.35 to US$0.49 and quarterly losses from US$24.7 million to US$34.6 million. The key question for...
NYSE:CI
NYSE:CIHealthcare

Cigna Group (CI) Margin Improvement To 2.2% Challenges Skeptical Earnings Narratives

Cigna Group (CI) has wrapped up FY 2025 with fourth quarter revenue of US$72.5b, basic EPS of US$4.67 and net income of US$1,234m, putting a clear spotlight on how the year’s strong headline numbers translate into underlying profitability. The company has seen quarterly revenue move from US$65.6b in Q4 2024 to US$72.5b in Q4 2025, with basic EPS shifting from US$5.13 to US$4.67 over the same period. Trailing 12 month EPS reached US$22.33 on net income of US$5,957m, highlighting a year in...
NasdaqGM:GDEN
NasdaqGM:GDENHospitality

Golden Entertainment (GDEN) Loss Deepens In Q4 EPS Miss Challenges Profit-Recovery Narrative

Golden Entertainment (GDEN) has wrapped up FY 2025 with Q4 revenue of US$155.6 million and a basic EPS loss of US$0.33, alongside net income excluding extra items of a US$8.5 million loss. Over recent periods, the company has seen quarterly revenue move between US$154.8 million and US$164.2 million, while EPS has swung from a profit of US$0.18 in Q3 2024 to a loss of US$0.33 in Q4 2025. This leaves investors watching how quickly margins can stabilize from here. See our full analysis for...
NYSE:GWW
NYSE:GWWTrade Distributors

Assessing W.W. Grainger (GWW) Valuation After Its Better Than Expected Earnings And Upgraded Outlook

What the latest earnings mean for W.W. Grainger (GWW) investors W.W. Grainger (GWW) recently posted quarterly results that topped expectations on both earnings and revenue, while management laid out full year guidance that points to higher projected EPS and sales compared with its latest reported figures. See our latest analysis for W.W. Grainger. At a share price of $1,144.73, W.W. Grainger has seen a 20.67% 90 day share price return and a 68.51% three year total shareholder return,...
NasdaqCM:RKLB
NasdaqCM:RKLBAerospace & Defense

Rocket Lab (RKLB) Q4 Loss Of US$52.9 Million Tests Profitability Narratives

Rocket Lab (RKLB) has just put fresh numbers on the table for FY 2025, reporting Q4 revenue of US$179.7 million and a basic EPS loss of US$0.09, alongside trailing 12 month revenue of US$601.8 million and a full year EPS loss of US$0.37. The company’s quarterly revenue moved from US$132.4 million in Q4 2024 to US$179.7 million in Q4 2025, while quarterly EPS losses ranged between US$0.10 and US$0.13 across FY 2025. As a result, the focus for investors is on how quickly those losses can be...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

Is Ocular Therapeutix (OCUL) Pricing Reflecting Its Recent Volatility And DCF Implied Upside

Investors may be wondering whether Ocular Therapeutix at US$8.94 is starting to look interesting on price, or if the recent moves are already baking in the upside. The stock has been volatile lately, with a 14.9% gain over the last 7 days, a 13.0% decline over 30 days, a 24.4% decline year to date, a 25.2% return over 1 year, and 51.3% over 3 years, while still sitting 51.7% lower over 5 years. These swings have kept Ocular Therapeutix on the radar of investors watching for changing...
NasdaqGS:ICFI
NasdaqGS:ICFIProfessional Services

ICF International (ICFI) Margin Compression Challenges Long Term EPS Growth Narrative

ICF International (ICFI) closed out FY 2025 with Q4 revenue of US$443.7 million and basic EPS of US$0.95, alongside trailing twelve month revenue of about US$1.9 billion and EPS of US$5.0 that frame the latest print against a full year backdrop. Over recent quarters, the company has seen revenue move from US$516.9 million in Q3 2024 to US$487.6 million in Q1 2025 and US$443.7 million in Q4 2025, while basic EPS shifted from US$1.74 to US$1.45 and then to US$0.95. This sets up a results season...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

Globalstar (GSAT) Losses Narrow Sharply Which Reinforces Bullish Profitability Narratives

Globalstar (GSAT) has released its FY 2025 numbers, reporting Q4 revenue of US$72 million and a basic EPS loss of US$0.11. On a trailing twelve month basis, revenue came in at US$273 million and basic EPS was a loss of US$0.15. Over recent periods, the company has seen quarterly revenue range from US$60 million to US$74 million and basic EPS swing between a profit of US$0.13 and losses of up to US$0.42. This gives a clear view of how volatile margins have been as the business works through...
NYSE:MPT
NYSE:MPTHealth Care REITs

FFO Recovery At Medical Properties Trust (MPW) Challenges Bearish Cash Flow Narratives

Latest Earnings Snapshot Medical Properties Trust (MPW) has wrapped up FY 2025 with fourth quarter revenue of US$294.5 million, basic EPS of US$0.03, and Funds From Operations of US$115.9 million, giving investors a cleaner read on cash based performance for a healthcare REIT. The company has seen revenue move from US$247.5 million in Q3 2024 to US$234.8 million in Q4 2024 and then to US$294.5 million in Q4 2025. Basic EPS shifted from a loss of US$0.69 in Q4 2024 to a loss of US$0.20 in Q1...
NYSE:IBM
NYSE:IBMIT

Reassessing IBM (IBM) Valuation After Recent Share Price Pullback

If you are looking at International Business Machines and wondering whether the recent price gives you a fair entry point, you will want to see how its current market value stacks up against a few different valuation yardsticks. IBM shares last closed at US$240.21, with returns of 6.6% decline over 7 days, 18.3% decline over 30 days, 17.6% decline year to date, 2.5% decline over 1 year, 105.4% over 3 years and 149.9% over 5 years. These moves may have shifted how the market is pricing its...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Assessing Liquidia (LQDA) Valuation After Recent Share Price Volatility And YUTREPIA Growth Expectations

Event context and recent share performance Liquidia (LQDA) has drawn investor attention after recent share price swings, with the stock rising about 0.8% over the past day but recording a 7.6% decline over the past week. Those short term moves sit alongside a month drop of about 26% and a past 3 months decline of roughly 4.9%. This puts the current share price of US$31.03 in a different context than longer term total returns. See our latest analysis for Liquidia. Zooming out, Liquidia’s...
NasdaqGS:MMYT
NasdaqGS:MMYTHospitality

The Bull Case For MakeMyTrip (MMYT) Could Change Following OpenAI-Powered Myra Travel Integration – Learn Why

In February 2026, OpenAI announced a collaboration with MakeMyTrip Limited to power new AI-led travel discovery and booking features within the Myra interface, using OpenAI's APIs to turn conversational queries into structured, transaction-ready options across flights, hotels and ancillary services. This shift places MakeMyTrip directly inside AI-driven travel planning journeys, potentially moving it from passive search exposure to active, intent-driven trip curation and bookings. We’ll now...
NYSE:VTEX
NYSE:VTEXIT

VTEX NYSE VTEX Margin Expansion Reinforces Bullish Earnings Narrative After FY 2025 Results

VTEX (NYSE:VTEX) closed out FY 2025 with Q4 revenue of US$68.0 million and basic EPS of US$0.06, alongside net income of US$9.8 million. On a trailing twelve month basis, revenue was US$240.5 million with basic EPS of US$0.11 and net income of US$20.0 million. The company reported quarterly revenue moving from US$54.2 million in Q1 2025 to US$68.0 million in Q4 and basic EPS increasing from US$0.00 in Q1 to US$0.06 in Q4, indicating higher quarterly earnings contributions across the year...
NYSE:BHR
NYSE:BHRHotel and Resort REITs

Braemar Hotels And Resorts (BHR) FFO Volatility Tests Bullish Cash Flow Narratives

Braemar Hotels & Resorts (BHR) has closed out FY 2025 with fourth quarter revenue of US$165.6 million and a basic EPS loss of US$0.67, rounding off a year in which trailing twelve month revenue came in at US$704.0 million alongside a basic EPS loss of US$1.08. Over recent quarters, the company has seen revenue move from US$215.8 million in Q1 2025 to US$143.6 million in Q3 2025 and then to US$165.6 million in Q4 2025. Basic EPS has ranged from a loss of US$0.04 in Q1 2025 to a loss of US$0.67...
NYSE:ORA
NYSE:ORARenewable Energy

Ormat Technologies (ORA) Margin Decline Tests Bullish Earnings Growth Narrative

Ormat Technologies (ORA) just closed out FY 2025 with Q4 revenue of US$276.0 million and basic EPS of US$0.52, alongside trailing 12 month revenue of US$989.5 million and EPS of US$2.04 that frame the latest print in a full year context. The company has seen quarterly revenue move from US$211.8 million in Q3 2024 to US$276.0 million in Q4 2025, with basic EPS across those same quarters running between US$0.37 and US$0.67. This has set up a story where investors are watching how the 12.5% net...
NasdaqGS:TLN
NasdaqGS:TLNRenewable Energy

Talen Energy (TLN) EPS Loss In Q4 2025 Tests Bullish Data Center Narratives

Talen Energy (TLN) closed out FY 2025 with Q4 revenue of US$771 million and a basic EPS loss of US$7.95, while prior quarters in the year ranged from revenue of US$454 million to US$770 million and EPS between a loss of US$2.94 and EPS of US$4.53. Over the past six reported quarters, revenue has moved between US$454 million and US$771 million and quarterly EPS has swung from a loss of US$7.95 to EPS of US$4.53, presenting a picture where top line scale is relatively stable but earnings...
NYSE:ABG
NYSE:ABGSpecialty Retail

A Look At Asbury Automotive Group’s Valuation After Recent Share Price Weakness

Asbury Automotive Group (ABG) has drawn investor attention after recent share price moves, with the stock showing negative returns over the past week, month, past 3 months and year, despite a positive 5 year tally. See our latest analysis for Asbury Automotive Group. With the share price at US$213.78, Asbury Automotive Group’s recent 1 month share price return of a 12.35% decline and 1 year total shareholder return of a 20.35% decline point to fading momentum, even though the 5 year total...
NYSE:AGO
NYSE:AGOInsurance

Assured Guaranty (AGO) Net Margin Surge Challenges Bearish Earnings Narratives

Assured Guaranty’s FY 2025 Earnings Snapshot Assured Guaranty (AGO) has rounded out FY 2025 with fourth quarter revenue of US$235 million and basic EPS of US$2.55. Trailing twelve month figures show revenue of US$935 million and EPS of US$10.33, alongside earnings growth of 33.8% over the past year. Over recent quarters the company has seen revenue move from US$289 million in Q1 2025, with EPS of US$3.50, to US$198 million in Q2, US$213 million in Q3, and US$235 million in Q4, as trailing net...